Procter & Gamble (NYSE:PG) Receives Neutral Rating from DA Davidson

Procter & Gamble (NYSE:PG)‘s stock had its “neutral” rating reissued by DA Davidson in a research note issued on Tuesday, Benzinga reports. They currently have a $159.00 price objective on the stock. DA Davidson’s target price points to a potential downside of 7.75% from the stock’s current price. DA Davidson also issued estimates for Procter & Gamble’s Q1 2025 earnings at $1.90 EPS, FY2025 earnings at $6.98 EPS and FY2026 earnings at $7.40 EPS.

Other equities analysts have also issued reports about the company. BNP Paribas assumed coverage on Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective on the stock. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research report on Thursday, August 29th. StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. JPMorgan Chase & Co. upped their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Nine equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $176.21.

Procter & Gamble Stock Down 0.7 %

Shares of NYSE PG opened at $172.36 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. Procter & Gamble has a 52 week low of $142.50 and a 52 week high of $177.94. The stock has a market capitalization of $406.78 billion, a P/E ratio of 28.16, a PEG ratio of 3.67 and a beta of 0.41. The stock’s fifty day moving average is $171.72 and its 200 day moving average is $167.00.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same quarter in the previous year, the business posted $1.37 earnings per share. The business’s revenue for the quarter was down .1% on a year-over-year basis. Sell-side analysts forecast that Procter & Gamble will post 6.97 earnings per share for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other news, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares in the company, valued at approximately $2,212,043.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares in the company, valued at approximately $2,212,043.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock valued at $65,140,718 in the last 90 days. Corporate insiders own 0.17% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Large investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the second quarter valued at $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble during the second quarter valued at about $29,000. Ruedi Wealth Management Inc. grew its holdings in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares during the period. POM Investment Strategies LLC bought a new stake in Procter & Gamble during the second quarter valued at about $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble in the second quarter valued at about $36,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.